Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 14 results found. Search for [ human immunodeficiency virus ]

Results 1 to 14 of 14
Associated Press
February 15, 2021
Legitimate questions about the virus created perfect conditions for conspiracy theories. In the absence of knowledge, guesswork and propaganda flourished


BusinessToday.In
December 28, 2020
According to the World Health Organisation (WHO), super gonorrhea may become drug-resistant, including resistance to recommended treatments such as azithromycin, which has seen an increase in its usage during the coronavirus pandemic


BusinessToday.In
December 24, 2020
The World Health Organisation clearly states the sexually transmitted infection (STI) may become even more resistant to the recommended treatments like azithromycin


BusinessToday.In
December 1, 2020
World Aids Day: Acquired Immunodeficiency Syndrome (AIDS) is a deadly health condition caused by the human immunodeficiency virus (HIV)


Reuters
May 9, 2020
The findings, published in the Lancet medical journal, showed that on average, people who got the triple drug reached the point of no detectable virus five days earlier than those in the control group - at 7 days versus 12 days


Joe C Mathew
February 22, 2020
Ever since India changed its intellectual property laws in 2005 to permit product patents in India, the country has been increasingly granting patents


PTI
December 30, 2018
Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of HIV from the American market


PTI
December 30, 2018



PTI
November 18, 2018



PTI
November 16, 2018



BT Online
New Delhi, April 5, 2017
BSE Sensex ended the day 29,974.24, up 64.02 points after touching and intra day high of 30,007, while the NSE Nifty held above its 9,250-mark closing the day at 9,265.15, up 27.30 points.


Joe C Mathew
November 26, 2015
The agenda for the present Parliament session includes 19 Bills currently pending for consideration, and passage and introduction of 14 new Bills.


PTI
Mumbai, December 26, 2014
The home-grown pharma major has received final approval from the US health regulator for its Lamivudine tablets in strengths of 150 mg and 300 mg, Lupin said in a statement.


BT Online Bureau
New Delhi, December 18, 2012
Drug firm Aurobindo Pharma has received the US health regulator's final approval to market Abacavir Tablets, used in the treatment of Human Immunodeficiency Virus (HIV), in the American market.


PAGES 1 OF 1